[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-340997-105":59,"doc-detail-340997-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","functional-enrichment-analysis-reveals-the-involvement-of-dars2-in-multiple-biological-pathways-and-its-potential-as-a-therapeutic-target-in-esophageal-carcinoma","Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma","","The study investigates Aspartyl tRNA synthetase 2 (DARS2), a mitochondrial tRNA synthesis enzyme essential for normal mitochondrial function and protein production, and evaluates its role in esophageal carcinoma (ESCA), where the function remains unclear. Pan-cancer and ESCA transcriptional datasets from UCSC XENA, TCGA, and GEO are used for differential expression and clinicopathological association, followed by GO/KEGG/GSEA. In vitro ESCA experiments test DARS2 knockdown effects on proliferation, migration, apoptosis, cell cycle, and glycolysis, while ceRNA network analyses connect DARS2 with glycolysis and m6A-related regulation. Results link DARS2 overexpression to ESCA progression and suggest DARS2-related m6A control via METTL3 and YTHDF1, supporting DARS2 as a therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/functional-enrichment-analysis-reveals-the-involvement-of-dars2-in-multiple-biological-pathways-and-its-potential-as-a-therapeutic-target-in-esophageal-carcinoma/340997/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/functional-enrichment-analysis-reveals-the-involvement-of-dars2-in-multiple-biological-pathways-and-its-potential-as-a-therapeutic-target-in-esophageal-carcinoma/340997.png","ImageObject",300,407,{"name":92,"@type":93},"Finn","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main research objective regarding DARS2 in ESCA?","Question",{"text":112,"@type":113},"To determine whether DARS2 is involved in esophageal carcinoma, and to clarify its potential as a therapeutic target by linking it to biological pathways and regulatory mechanisms.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Which data sources and analyses are used to study DARS2 expression in tumors?",{"text":117,"@type":113},"Transcriptional data are downloaded from UCSC XENA, TCGA, and GEO to assess differential expression of DARS2 between tumor and normal samples, its correlation with clinical features, and to perform GO, KEGG, and GSEA enrichment analyses.",{"name":119,"@type":110,"acceptedAnswer":120},"How do experiments validate the functional role of DARS2 in ESCA cells?",{"text":121,"@type":113},"In vitro experiments interfere with DARS2 expression in ESCA cells and confirm significant impacts on proliferation, migration, apoptosis, cell cycle progression, and glycolysis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},340997,1790125587,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},34359740700684,"https://ap-avatar.wpscdn.com/avatar/1f400023980c374ae676?_k=1777273430885731487","[www.aging-us.com](www.aging-us.com) AGING 2024, Vol. 16, No. 4  \nResearch Paper  \nFunctional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma  \nXu-Sheng Liu1,*, Zi-Yue Liu1,*, Dao-Bing Zeng1, Jian Hu2, Xuan-Long Chen3, Jiao-Long Gu4, Yan Gao1, Zhi-Jun Pei1  \n1 Department of Nuclear Medicine, Hubei Provincial Clinical Research Center for Umbilical Cord Blood Hematopoietic Stem Cells, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China 2 Department of Critical Care Medicine, Danjiangkou First Hospital, Danjiangkou 420381, Hubei, China 3 Department of Medical Ultrasound, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China 4 Department of Obstetrics and Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan 442000, Hubei, China *Equal contribution  \nCorrespondence to: Xu-Sheng Liu, Zhi-Jun Pei; email: [lxsking@taihehospital.com](lxsking@taihehospital.com), [pzjzml1980@taihehospital.com](pzjzml1980@taihehospital.com)[ ](pzjzml1980@taihehospital.com)[Keywords:](Keywords: DARS2)[ DARS2](Keywords: DARS2), esophageal carcinoma, glycolysis, m6A, ceRNA  \nReceived: October 6, 2023 Accepted: January 17, 2024 Published: February 20, 2024  \nCopyright: © 2024 Liu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.  \nABSTRACT  \nObjective: The enzyme Aspartyl tRNA synthetase 2 (DARS2) is a crucial enzyme in the mitochondrial tRNA synthesis pathway, playing a critical role in maintaining normal mitochondrial function and protein synthesis. However, the role of DARS2 in ESCA is unclear.  \nMaterials and Methods: Transcriptional data of pan-cancer and ESCA were downloaded from UCSC XENA, TCGA, and GEO databases to analyze the differential expression of DARS2 between tumor samples and normal samples, and its correlation with clinicopathological features of ESCA patients. R was used for GO, KEGG, and GSEA functional enrichment analysis of DARS2 co-expression and to analyze the connection of DARS2 with glycolysis and m6A-related genes. In vitro experiments were performed to assess the effects of interfering with DARS2 expression on ESCA cells. TarBase v.8, mirDIP, miRTarBase, ENCORI, and miRNet databases were used to analyze and construct a ceRNA network containing DARS2.  \nResults: DARS2 was overexpressed in various types of tumors. In vitro experiments confirmed that interfering with DARS2 expression significantly affected the proliferation, migration, apoptosis, cell cycle, and glycolysis of ESCA cells. DARS2 may be involved in multiple biological pathways related to tumor development. Furthermore, correlation and differential analysis revealed that DARS2 may regulate ESCA m6A modification through its interaction with METTL3 and YTHDF1 . A ceRNA network containing DARS2, DLEU2/has-miR-30a- 5p/DARS2, was successfully predicted and constructed.  \nConclusions: Our findings reveal the upregulation of DARS2 in ESCA and its association with clinical features, glycolysis pathway, m6A modification, and ceRNA network. These discoveries provide valuable insights into the molecular mechanisms underlying ESCA.  \nINTRODUCTION  \nEsophageal carcinoma (ESCA), one of the most prevalent gastrointestinal malignancies, is ranked  \nseventh globally among the most common types of cancer and sixth among the leading causes of cancerrelated mortality [1] . Furthermore, in the Chinese region, the incidence rate of esophageal cancer ranks  \n3934  \nfifth among new cases, exhibiting a steady upward trend over the years [2, 3] . Esophageal cancer is typically classified into two major types, namely, esophageal adenocarcinoma (ECA) and esophageal squamous cell carcinoma (ESCC), with the latter being the most predominant [4] .","cbCaibCp3LCFyi6i","https://ap.wps.com/l/cbCaibCp3LCFyi6i","pdf",4226430,21,"English","# Abstract\n## Objective\n## Materials and Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main research objective regarding DARS2 in ESCA?\",\"answer\":\"To determine whether DARS2 is involved in esophageal carcinoma, and to clarify its potential as a therapeutic target by linking it to biological pathways and regulatory mechanisms.\"},{\"question\":\"Which data sources and analyses are used to study DARS2 expression in tumors?\",\"answer\":\"Transcriptional data are downloaded from UCSC XENA, TCGA, and GEO to assess differential expression of DARS2 between tumor and normal samples, its correlation with clinical features, and to perform GO, KEGG, and GSEA enrichment analyses.\"},{\"question\":\"How do experiments validate the functional role of DARS2 in ESCA cells?\",\"answer\":\"In vitro experiments interfere with DARS2 expression in ESCA cells and confirm significant impacts on proliferation, migration, apoptosis, cell cycle progression, and glycolysis.\"}]","Functional enrichment analysis reveals the involvement of DARS2 in multiple biological pathways and its potential as a therapeutic target in esophageal carcinoma | PDF",1790039877,53,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f971314e1e90385a4bccc5bd9e2df1e1.webp",983,1272,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dc41393c29034977dabc0c77b43c85be.webp",982,1270,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/effbacc4ee4d27f429a475d7ad215cff.webp",981,1269,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/0c101baa73bae29fd5d07e9e809a3819.webp",980,1268]